Viewing Study NCT00449839



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00449839
Status: COMPLETED
Last Update Posted: 2009-07-02
First Post: 2007-03-20

Brief Title: Changes of the Infusion Rate in Insulin Pump Treatment
Sponsor: Aarhus University Hospital
Organization: University of Aarhus

Study Overview

Official Title: Changes of the Infusion Rate in Insulin Pump Treatment A Randomized Unblinded Cross-Over Study
Status: COMPLETED
Status Verified Date: 2009-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A pharmacokinetic study of insulin pump treatment using Insulin Aspart The study consist of three different periods A B and C where a constant the insulin infusion rate is given during the periods In period B and C will the infusion start with a bolus

It will be investigated if a steady state of insulin will be obtained faster in period B and C then A
Detailed Description: A pharmacokinetic study of insulin pump treatment using Insulin Aspart The study consist of three different periods A B and C where a constant the insulin infusion rate is given during the periods Each period will last 12 hours and blood will be drawn to measure absorbed Insulin Aspart During period A will a constant the infusion rate of insulin be given In period B and C will there at the start of the constant infusion rate be given a bolus The bolus in period C is calculated on the basis of the results in period B therefore will all participants experience period C last where as period A and B is randomized cross-over Period C is written in the protocol as optional and it is evaluated after period A and B if period C will be performed

The hypothesis is that steady state of insulin will be obtained faster in period B and C than A

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None